학술논문

Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg doses
Document Type
Article
Source
In Journal of Clinical Lipidology November-December 2019 13(6):979-988
Subject
Language
ISSN
1933-2874